Resistance to Tyrosine Kinase Inhibition Therapy for Chronic Myelogenous Leukemia: A Clinical Perspective and Emerging Treatment Options
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.03.018
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2013
Authors
Publisher
Elsevier BV